Yeah its a bit unfortunate that there were adjustments to valuations in the biotech sector in the US which led to the sell down.Mesoblast has had nothing but good news on alot of fronts.Just hang in there this stock is going places, watch out shorters.The CHF trial announcement regarding stage 4 is further vindication that the technolgy works and expands market potential for Mesoblast,also including stage 4 patients in the current trial will bode well for efficacy outcomes. GVHD Japan announcement fantastic second biggest health care market in the world now Canada and New Zealand markets will jump on board due to this announcement.Its all on track markets go up and markets go down,good buying opportunity now!
Yeah its a bit unfortunate that there were adjustments to...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |